These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 401986)
1. [Use of demeclotetracycline in the treatment of hyponatremia in cirrhotic ascitis]. Delavelle F; Becchio J; Fries D Nouv Presse Med; 1977 Jan; 6(21):101-4. PubMed ID: 401986 [TBL] [Abstract][Full Text] [Related]
2. [Demeclocycline: a new treatment of water-salt retention in cirrhosis and refractory ascites]. Poupon R; Gustot P; Darnis F Nouv Presse Med; 1976 Sep; 5(31):1993-4. PubMed ID: 824615 [No Abstract] [Full Text] [Related]
3. [Demethylchlortetracycline treatment of cirrhotic ascites with hyponatremia]. Martin J; Codinach N; Conte-Devolx B; Gauthier A Nouv Presse Med; 1977 Dec; 6(43):1066. PubMed ID: 414203 [No Abstract] [Full Text] [Related]
4. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts]. Vesin P Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553 [No Abstract] [Full Text] [Related]
5. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Wong F; Blei AT; Blendis LM; Thuluvath PJ Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203 [TBL] [Abstract][Full Text] [Related]
6. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin]. Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of water-mineral retention in cirrhotic patients with Demeclocycline]. de Troyer A; Zegers de Beyl D; Demanet JC J Urol Nephrol (Paris); 1977; 83(4-5):302-6. PubMed ID: 408512 [No Abstract] [Full Text] [Related]
10. Comparative efficacy of spironolactone and hydrochlorothiazide (separately and in combination) in cirrhotic edema. Munshi CP; Sawkar LA; Vaidya PM; Gulati OD J Assoc Physicians India; 1967 Dec; 15(12):583-9. PubMed ID: 4870785 [No Abstract] [Full Text] [Related]
11. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites]. Traina M; Vizzini GB Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409 [TBL] [Abstract][Full Text] [Related]
12. [Furosemide-amiloride combination in the treatment of ascitic-edema in patients with hepatic cirrhosis]. Uribe M; Rojas S; Casián C; Sierra JG; Moreno J; Lewis H; Guevara L Rev Gastroenterol Mex; 1980; 45(2):63-8. PubMed ID: 7403764 [TBL] [Abstract][Full Text] [Related]
13. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites. Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218 [TBL] [Abstract][Full Text] [Related]
14. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis. Radó JP; Sawinsky I; Juhos E Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353 [TBL] [Abstract][Full Text] [Related]
15. [Inappropriate antidiuresis and its treatment with a vasopressin inhibitor]. Demanet JC; De Troyer A; Zegers de Beyl D Bull Mem Acad R Med Belg; 1978 Mar; 133(3):222-32. PubMed ID: 96894 [No Abstract] [Full Text] [Related]
16. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786 [TBL] [Abstract][Full Text] [Related]
17. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. Miller PD; Linas SL; Schrier RW JAMA; 1980 Jun; 243(24):2513-5. PubMed ID: 6770106 [TBL] [Abstract][Full Text] [Related]
18. [Hyponatremia in cirrhosis with ascites]. Bronzi G; Orlando D; De Feudis L; Delle Monache G; Scudieri M; Sergiacomo L; Bernardi M; Pesa O Minerva Med; 1990 Sep; 81(9):591-6. PubMed ID: 2234478 [TBL] [Abstract][Full Text] [Related]
19. [Aldosterone and renin in liver cirrhosis with ascites]. Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137 [TBL] [Abstract][Full Text] [Related]
20. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. Decaux G J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]